Cryo-EM reveals mechanisms of angiotensin I-converting enzyme allostery and dimerization

Hypertension (high blood pressure) is a major risk factor for cardiovascular disease, which is the leading cause of death worldwide. The somatic isoform of angiotensin I-converting enzyme (sACE) plays a critical role in blood pressure regulation, and ACE inhibitors are thus widely used to treat hypertension and cardiovascular disease. Our current understanding of sACE structure, dynamics, function, and inhibition has been limited because truncated, minimally glycosylated forms of sACE are typically used for X-ray crystallography and molecular dynamics simulations. Here, we report the first cryo-EM structures of full-length, glycosylated, soluble sACE (sACE(S1211)). Both monomeric and dimeric forms of the highly flexible apo enzyme were reconstructed from a single dataset. The N- and C-terminal domains of monomeric sACE(S1211) were resolved at 3.7 and 4.1 angstrom, respectively, while the interacting N-terminal domains responsible for dimer formation were resolved at 3.8 angstrom. Mechanisms are proposed for intradomain hinging, cooperativity, and homodimerization. Furthermore, the observation that both domains were in the open conformation has implications for the design of sACE modulators.

Automated summary

This study presents the first cryo-EM structures of full-length, glycosylated, soluble sACE (sACE(S1211)), revealing both monomeric and dimeric forms of the enzyme. The structures provide insights into the intradomain hinging, cooperativity, and homodimerization mechanisms of sACE. The observation of open conformation has implications for the design of sACE modulators.